Community
2026/5/24
Beyond Benchmark Scores: Clinical Integration and Real-World Evidence
This month’s healthcare GenAI research highlights a major transition from benchmark-driven development toward real-world clinical integration and evidence generation. New studies demonstrated advances in multimodal diagnostic AI, collaborative clinician-AI workflows, and AI-supported screening and documentation. At the same time, leading journals emphasized that healthcare AI claims must be supported by rigorous clinical evidence, workflow evaluation, continuous monitoring, and accountability frameworks. Together, these developments signal that the next phase of healthcare GenAI will be defined not only by model performance, but by how effectively AI improves real-world clinical decision-making, patient outcomes, operational efficiency, and health equity.
2025/12/15
At the Chen Institute’s AI Accelerated Science Symposium on October 28, 2025, ELHS Institute founder Dr. AJ Chen proposed a new vision for Open Clinical AI Science (OCAIS) to accelerate the clinical impact of generative AI. The framework delivers free GenAI-based disease prediction services to clinical teams worldwide, including low-resource settings, enabling large-scale participation in clinical evidence generation. By converging GenAI with task-specific Learning Health System units, this approach aims to shorten evidence-generation timelines from decades to years and help prevent GenAI from repeating past failures in health care innovation.
2025/10/25
Dr. AJ Chen delivered a keynote at the Tsinghua Health AI Summit on converging generative AI (GenAI) and Learning Health Systems (LHS) to improve clinical diagnosis and reduce global health disparities. He presented the ELHS Institute’s ML-enabled LHS framework, supported by Nature- and JAMIA-published studies, showing how GenAI embedded in LHS units can enable scalable, responsible evidence generation and democratize high-standard predictive care worldwide.
